AzTrials
AzTrials

Spinal Stenosis LumbarNCT07482826

Full-Endoscopic Decompression vs. Endoscopic Lumbar Fusion for Middle-Aged and Older Adults With Spinal Stenosis

A study testing Full-Endoscopic Decompression and Endoscopic Lumbar Interbody Fusion in people with Spinal Stenosis Lumbar, run by The First Affiliated Hospital with Nanjing Medical University.

Not yet recruiting

Opening soon. The study is approved but enrolment has not started yet. Sites may already take enquiries.

Sites and contacts
Official record
Search all trials

Trial summary

Lumbar Spinal Stenosis (LSS) is a syndrome characterized by anatomical narrowing of the central canal, lateral recess, or intervertebral foramen of the lumbar spine, leading to compression of nerve roots, the cauda equina, and their associated blood supply. Read more about this study

Who is it for?
Ages 50 to 75 years
Conditions the study is for
Spinal Stenosis Lumbar
What is being tested?
Full-Endoscopic Decompression and Endoscopic Lumbar Interbody Fusion
Type of treatment
Surgery or procedure
Could I receive a placebo?
No, everyone receives an active treatment
How many people
176 participants
Where
No sites listed yet
Study dates
1 Apr 2026to 31 Dec 2029
Phase
Interventional
Are there results?
Not yet: the study is under way

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 50 to 75 years
  • All sexes
  • No healthy volunteers
  • Adult, Older adult

Who may be able to join

  • Aged between 50 and 75 years, regardless of gender.
  • A definitive diagnosis of lumbar spinal stenosis, presenting with typical clinical symptoms (e.g., lower extremity radiating pain, neurogenic claudication) and signs, confirmed by imaging (MRI or CT).
  • The lesion involves only a single spinal segment (L2-S1).
  • Failed to respond to at least three months of systematic conservative treatment, with a significant impact on quality of life, and the patient has a clear willingness to undergo surgery.
  • (Clinical equipoise) After evaluation by at least two senior spine surgeons, both agree that the patient's condition meets the surgical indications for both full-endoscopic decompression and endoscopic lumbar interbody fusion.
  • The patient fully understands the randomized nature of this study (including random assignment and the relinquishment of choice by both the physician and the patient) and voluntarily signs the Informed Consent Form.

Who cannot join

  • Clear indications for fusion: Degenerative spondylolisthesis greater than Meyerding Grade I, presence of lumbar spondylolysis, or evidence of definite lumbar instability on flexion-extension radiographs (e.g., segmental translation > 3 mm or angular change > 10°).
  • Clear indications for decompression alone: Stenosis caused solely by soft disc herniation, without concomitant bony spinal canal or lateral recess stenosis.
  • Spinal stenosis due to non-degenerative causes: Presence of spinal stenosis caused by fracture, spinal tumor, active infection, or inflammatory disease (e.g., ankylosing spondylitis, rheumatoid arthritis).
  • Severe spinal structural abnormalities: Presence of severe spinal deformity (e.g., degenerative scoliosis with a Cobb angle > 20°).
  • History of relevant prior surgery: Previous lumbar surgery at the same or an adjacent segment.
  • Systemic diseases precluding tolerance to surgery: Presence of severe dysfunction of major organs (e.g., heart, lung, liver, kidney) or an American Society of Anesthesiologists (ASA) classification > III, indicating an inability to tolerate anesthesia or surgery upon evaluation.
  • Comorbidities that may confound outcome assessment: Presence of other conditions that could cause lower extremity claudication or dysfunction, such as severe hip or knee osteoarthritis (including a history of total hip or knee arthroplasty), peripheral vascular claudication, or polyneuropathy. Presence of other neurological or muscular system disorders that could seriously affect treatment evaluation (e.g., Parkinson's disease, amyotrophic lateral sclerosis).
  • Participation in other studies: Currently participating in other clinical trials that could potentially influence the results of this study.

Trial locations and contacts

No sites are listed yet. Contact the study team or a site near you to ask about taking part.

Yongxin Ren, M.D./Ph.D contact

+86 13585162283

renyongxinjsph@163.com

About this study

Official title: Full-Endoscopic Decompression (FED) Versus Endoscopic Lumbar Interbody Fusion (Endo-LIF) in Middle-Aged and Older Adults With Lumbar Spinal Stenosis: A Prospective Randomized Controlled Trial

Lumbar Spinal Stenosis (LSS) is a syndrome characterized by anatomical narrowing of the central canal, lateral recess, or intervertebral foramen of the lumbar spine, leading to compression of nerve roots, the cauda equina, and their associated blood supply. Its clinical manifestations primarily include neurogenic intermittent claudication and/or radiating pain and numbness in the lower extremities. LSS is a common cause of disabling low back and leg pain and neurogenic claudication in middle-aged and older adults. Epidemiological studies confirm that its prevalence increases significantly with age, affecting approximately 11% of the general population and rising to 19.4% among individuals over 60. Against the backdrop of accelerating population aging in China, LSS not only severely threatens the quality of life and physical and mental health of middle-aged and older adults but also imposes a substantial economic burden on society.

For patients who do not respond to systematic conservative treatment, surgery can provide rapid relief from low back and leg pain. In recent years, high-quality evidence from randomized controlled trials (RCTs) has shown that in specific LSS subgroups with Grade I lumbar spondylolisthesis, the two-year clinical outcomes of decompression alone are non-inferior to those of decompression with instrumented fusion. This finding suggests that fusion is not an absolute indication for such patients and challenges the potential trend of overuse of fusion in clinical practice, prompting surgeons to more carefully evaluate the risk-benefit ratio of fusion surgery. However, it is important to note that this evidence primarily originates from traditional open surgical approaches and highly selected study populations. Therefore, whether these conclusions can be directly extrapolated to full-endoscopic techniques and their applicability in complex middle-aged and older patient populations with multiple comorbidities remain unclear and warrant further investigation.

Read more

Against this backdrop, minimally invasive spine surgery technology, guided by the core principle of "achieving maximum efficacy with minimal trauma," has developed rapidly. Over the past decade, full-endoscopic spine techniques, representing the concept of "ultra-minimally invasive" surgery, have made significant progress. This technology, relying on high-definition endoscopic systems, enables precise decompression of neural structures under a magnified and clear surgical field through tiny skin incisions less than 1 cm in diameter and sequentially dilated working channels. Its clinical advantages in reducing perioperative pain and accelerating postoperative recovery have been widely confirmed. Innovations in full-endoscopic techniques have allowed the classic clinical debate of "decompression alone versus decompression with fusion" to be re-examined within a new technological platform. However, high-quality prospective studies directly comparing full-endoscopic decompression alone with Endoscopic Lumbar Interbody Fusion (Endo-LIF) remain scarce, especially evidence specific to the unique patient population of middle-aged and older adults. Consequently, in current real-world clinical practice, a surgeon's choice between these two endoscopic procedures often relies more on personal clinical experience than on support from high-level evidence-based medicine.

Based on the aforementioned background, this study aims to conduct a prospective randomized controlled trial comparing the efficacy and safety of full-endoscopic decompression versus endoscopic fusion in middle-aged and older adult patients with LSS, thereby providing a scientific basis for individualized and precise surgical decision-making for this patient population.

Being tested
Full-Endoscopic Decompression, Endoscopic Lumbar Interbody Fusion
Keywords
Spinal Stenosis, Lumbar Vertebrae, Decompression, Surgical
Medical subject headings
Spinal Stenosis

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Full-Endoscopic DecompressionProcedure or surgery

    Standard full-endoscopic decompression (with a choice of interlaminar or transforaminal approach); performed solely for the purpose of thorough neural decompression, with no implantation of any internal fixation or fusion devices.

  • Endoscopic Lumbar Interbody FusionProcedure or surgery

    Standard Endo-LIF; while completing decompression, an interbody fusion cage (Cage) and a percutaneous pedicle screw system must be implanted to achieve segmental fusion.

Study groups in NCT07482826
Study groupRoleWhat they receive
Full-Endoscopic Decompression GroupExperimentalNot described
Receives: Procedure: Full-Endoscopic Decompression
Endoscopic Lumbar Interbody Fusion GroupActive comparatorNot described
Receives: Procedure: Endoscopic Lumbar Interbody Fusion

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Oswestry disability index

    0 to 100; Higher scores indicate more severe disability; The ODI is a 10-item questionnaire assessing limitations in daily activities related to low back pain.

    Measured: Baseline (pre-surgery), and 1, 2 years post-surgery.

Secondary outcomes (2)
  1. Numeric Rating Scales

    0 to 10; Higher scores indicate more severe pain; Patients are asked to rate the average pain experienced during the past week, where 0 represents "no pain" and 10 represents "worst pain imaginable".

    Measured: Baseline (pre-surgery), and at 1, 3, 6 months, and 1, 2 years post-surgery.

  2. EuroQol 5-Dimension Questionnaire

    -0.59 to 1.0 (for the 5L version) / -0.59 to 1.0 (for the 3L version); Higher scores indicate better health-related quality of life; The EQ-5D-5L comprises five dimensions (mobility, self-care, usual activities, pain/discomfort, anxiety/depression) and a visual analogue scale (EQ-VAS). The index score is calculated based on country-specific value sets.

    Measured: Baseline (pre-surgery), and at 1, 3, 6 months, and 1, 2 years post-surgery.

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted19 Mar 2026
  2. Study start1 Apr 2026 (estimated)
  3. Primary completion1 Apr 2029 (estimated)
  4. Study completion31 Dec 2029 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Treatment
Allocation
Randomised
Intervention model
Parallel groups
Masking
Quadruple blind
Who is masked
Participant, Care provider, Investigator, Outcomes assessor
Enrolment
176 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT07482826
Sponsor's protocol ID
2025-SR-1281
Status last verified
Mar 2026
First submitted
15 Mar 2026
Last updated
27 Mar 2026
Results posted
No
Data monitoring committee
Yes
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
No

Questions about this trial

What is this clinical trial studying?

A study testing Full-Endoscopic Decompression and Endoscopic Lumbar Interbody Fusion in people with Spinal Stenosis Lumbar, run by The First Affiliated Hospital with Nanjing Medical University.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 6 inclusion and 8 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: opening soon, as of the sponsor's last update on 27 Mar 2026. Status can change between updates, so confirm with the study contact before making plans.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

This study is still under way. Results are not available in the source record yet.

How can a doctor refer a patient or contact the research team?

Contact Yongxin Ren, M.D./Ph.D (+86 13585162283, renyongxinjsph@163.com), or a site near the patient. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Oswestry disability index (time frame: Baseline (pre-surgery), and 1, 2 years post-surgery.). It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 27 Mar 2026.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in